Aurobindo Pharma shares jump after its subsidiary inks deal with Singapore firm

Aurobindo Pharma said on Wednesday that its subsidiary, CuraTeQ, has signed a letter of intent with a Singapore-based company, Merck Sharp & Dohme Singapore Trading Pte. Ltd. and its affiliates, for CMO operations. 

Aurobindo Pharma shares jump after its subsidiary inks
The parties under the said LOI intend to conclude the negotiations by March 31, 2024, Aurobindo Pharma said in a BSE filing. Photo: Aurobindo Pharma official website/Representative

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x